Dominique Lasne

3.2k total citations
93 papers, 1.4k citations indexed

About

Dominique Lasne is a scholar working on Hematology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Dominique Lasne has authored 93 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hematology, 29 papers in Surgery and 22 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Dominique Lasne's work include Platelet Disorders and Treatments (31 papers), Blood Coagulation and Thrombosis Mechanisms (22 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (18 papers). Dominique Lasne is often cited by papers focused on Platelet Disorders and Treatments (31 papers), Blood Coagulation and Thrombosis Mechanisms (22 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (18 papers). Dominique Lasne collaborates with scholars based in France, Switzerland and United States. Dominique Lasne's co-authors include Martine Aiach, Francine Rendu, Christilla Bachelot‐Loza, Sophie Susen, Delphine Borgel, Pierre Boutouyrie, Martine Alhenc‐Gelas, Christine Le Beller, Agnés Lillo‐Le Louët and Brigitte Jude and has published in prestigious journals such as Nature Communications, Blood and Critical Care Medicine.

In The Last Decade

Dominique Lasne

80 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominique Lasne France 21 650 562 344 330 216 93 1.4k
Dimitrios A. Tsakiris Switzerland 24 384 0.6× 511 0.9× 501 1.5× 530 1.6× 144 0.7× 81 1.6k
Anne Bauters France 15 633 1.0× 441 0.8× 458 1.3× 218 0.7× 185 0.9× 46 1.5k
Martin Besser United Kingdom 21 782 1.2× 524 0.9× 459 1.3× 377 1.1× 182 0.8× 71 2.0k
Pierre Toulon France 20 511 0.8× 219 0.4× 177 0.5× 352 1.1× 141 0.7× 85 1.2k
B. Kemkes‐Matthes Germany 23 897 1.4× 830 1.5× 642 1.9× 865 2.6× 328 1.5× 78 2.1k
Françoise Boehlen Switzerland 26 1.2k 1.8× 290 0.5× 386 1.1× 503 1.5× 61 0.3× 96 2.3k
Jari Petäjä Finland 19 351 0.5× 323 0.6× 201 0.6× 172 0.5× 77 0.4× 60 1.0k
Marco Marietta Italy 22 271 0.4× 257 0.5× 354 1.0× 320 1.0× 95 0.4× 71 1.1k
J. G. Kelton Canada 19 1.1k 1.7× 1.0k 1.8× 267 0.8× 520 1.6× 451 2.1× 28 2.1k
Simon McRae Australia 21 889 1.4× 385 0.7× 630 1.8× 742 2.2× 57 0.3× 60 1.7k

Countries citing papers authored by Dominique Lasne

Since Specialization
Citations

This map shows the geographic impact of Dominique Lasne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Lasne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Lasne more than expected).

Fields of papers citing papers by Dominique Lasne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominique Lasne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Lasne. The network helps show where Dominique Lasne may publish in the future.

Co-authorship network of co-authors of Dominique Lasne

This figure shows the co-authorship network connecting the top 25 collaborators of Dominique Lasne. A scholar is included among the top collaborators of Dominique Lasne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominique Lasne. Dominique Lasne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Godiér, Anne, Dominique Lasne, Anne‐Céline Martin, et al.. (2025). Management of bleeding and invasive procedures in patients treated with anti–factor XI(a) anticoagulants: proposals from the French Working Group on Perioperative Haemostasis and French Society of Thrombosis and Haemostasis. Research and Practice in Thrombosis and Haemostasis. 9(3). 102860–102860. 2 indexed citations
2.
Mourey, Guillaume, Valérie Eschwège, Dominique Lasne, et al.. (2025). Drug‐Specific Calibration: A Solution to Reagent Variability in Extended Half‐Life Factor IX Activity Measurements. Haemophilia. 31(6). 1307–1314.
3.
Bajolle, Fanny, et al.. (2025). Real-world use of rivaroxaban for the thromboprophylaxis in Congenital and Acquired Heart Disease: A Prospective Cohort Study. Archives of cardiovascular diseases. 118(8-9). S255–S255.
4.
Gay, Juliette, Richard Chocron, Fanny Bajolle, et al.. (2023). Heparin-induced thrombocytopenia in newborns: experience at a pediatric hospital and a literature review. Research and Practice in Thrombosis and Haemostasis. 7(7). 102214–102214.
5.
Borgel, Delphine, Dominique Lasne, Sylvain Renolleau, et al.. (2022). Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C. Nature Communications. 13(1). 2391–2391. 10 indexed citations
6.
Tardy, Brigitte, Michèle Piot, Martine Alhenc‐Gelas, et al.. (2021). Functional Flow Cytometric Assay for Reliable and Convenient Heparin-Induced Thrombocytopenia Diagnosis in Daily Practice. Biomedicines. 9(4). 332–332. 7 indexed citations
7.
Lasne, Dominique, Sonia Poirault‐Chassac, Tristan Mirault, et al.. (2021). Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome. British Journal of Haematology. 192(5). 909–921. 8 indexed citations
8.
Favier, Rémi, Annie Harroche, Dominique Lasne, et al.. (2021). Assessing bleeding risk in 18 children with Osteogenesis imperfecta. British Journal of Haematology. 192(4). 785–788. 2 indexed citations
9.
Hardy, Michaël, Jonathan Douxfils, Stéphanie Roullet, et al.. (2021). Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review. Journal of Clinical Medicine. 10(8). 1740–1740. 42 indexed citations
10.
Nougier, Christophe, Emmanuelle Jeanpierre, Catherine Ternisien, et al.. (2020). Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals). European Journal Of Haematology. 105(6). 675–681. 17 indexed citations
15.
Lasne, Dominique, et al.. (2011). Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity. Haemophilia. 18(3). e158–63. 11 indexed citations
16.
Alyanakian, Marie‐Alexandra, et al.. (2011). Concomitant lupus anticoagulant and monoclonal IgMκ antibody in a patient with bleeding tendency: A case report and literature review. American Journal of Hematology. 86(10). 868–871.
17.
Louët, Agnés Lillo‐Le, Pierre Boutouyrie, Martine Alhenc‐Gelas, et al.. (2004). Diagnostic score for heparin‐induced thrombocytopenia after cardiopulmonary bypass. Journal of Thrombosis and Haemostasis. 2(11). 1882–1888. 130 indexed citations
18.
Denninger, Marie‐Hélène, Édith Fressinaud, Marie‐Geneviève Huisse, et al.. (2000). Le PFA 100TM remplacera-t-il le temps de saignement ?. Hématologie. 6(1). 93–102. 1 indexed citations
19.
Lasne, Dominique & Martine Aiach. (2000). Exploration des fonctions plaquettaires par le PFA100TM : performances et limites. Sang thrombose vaisseaux. 12(2). 97–103. 1 indexed citations
20.
Lasne, Dominique, Véronique Pingault, Emmanuel Arnaud, et al.. (1997). Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphism. British Journal of Haematology. 99(4). 801–807. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026